BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36741315)

  • 1. Construction and verification of a novel prognostic risk model for kidney renal clear cell carcinoma based on immunity-related genes.
    Liu Y; Wu D; Chen H; Yan L; Xiang Q; Li Q; Wang T
    Front Genet; 2023; 14():1107294. PubMed ID: 36741315
    [No Abstract]   [Full Text] [Related]  

  • 2. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of
    Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
    Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
    [No Abstract]   [Full Text] [Related]  

  • 4. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
    Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
    Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
    Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
    Front Oncol; 2020; 10():570819. PubMed ID: 33628726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic Analysis on the Prognostic Value of Neurotransmitter Receptor-Related Genes in Kidney Renal Clear Cell Carcinoma.
    Zhang H; Wang N; Yu T; Li Q; Yang L; Su Y; Wang P; Liu J; Yang L; Zhang J
    Altern Ther Health Med; 2023 Nov; 29(8):356-365. PubMed ID: 37632962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma.
    Qiu J; Wang Z; Zhao L; Zhang P; Xu Y; Xia Q
    Front Mol Biosci; 2023; 10():1201155. PubMed ID: 37529377
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
    Xing Q; Ji C; Zhu B; Cong R; Wang Y
    Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
    Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
    J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
    Cheng L; Mi J; Zhang J; Huang H; Mo Z
    Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. System analysis of
    Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
    Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and validation of risk model of EMT-related prognostic genes for kidney renal clear cell carcinoma.
    Wu LL; Yuan SF; Lin QY; Chen GM; Zhang W; Zheng WE; Lin HL
    J Gene Med; 2023 Nov; 25(11):e3549. PubMed ID: 37271571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of an endoplasmic reticulum stress-related gene model for predicting prognosis and immune features in kidney renal clear cell carcinoma.
    Shen Y; Cao Y; Zhou L; Wu J; Mao M
    Front Mol Biosci; 2022; 9():928006. PubMed ID: 36120545
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma.
    Zhang J; Zhao Q; Huang H; Lin X
    BMC Urol; 2024 Jan; 24(1):26. PubMed ID: 38297313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma.
    Zhang M; Liu YF; Gao Y; Zhao C; Chen M; Pan KH
    Transl Oncol; 2023 Aug; 34():101693. PubMed ID: 37315507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 9-gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co-expression and regression analyses.
    Zhu W; Ding M; Chang J; Liao H; Xiao G; Wang Q
    Chem Biol Drug Des; 2023 Feb; 101(2):422-437. PubMed ID: 36053927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.